Abstract
Chromoendoscopy was introduced in 2003 as a novel 'red flag' technique that aimed to increase the sensitivity of identifying flat, neoplastic lesions in patients with ulcerative colitis. The improved sensitivity of chromoendoscopy over standard white-light endoscopy has been confirmed in European and Asian centers. This commentary discusses the findings from a prospective, controlled study from the Mount Sinai Hospital in New York. The findings of this study provide unequivocal evidence that chromoendoscopy is superior to white-light endoscopy in the detection of neoplasias in patients with IBD. The authors of this study identified a greater number of lesions and a higher number of patients with dysplasia by use of this method and targeted biopsy sampling compared with standard endoscopy with random biopsy sampling. Chromoendoscopy in combination with targeted biopsies, therefore, has emerged as the new standard of cancer surveillance in patients with ulcerative colitis, and we can expect this technique to be incorporated into clinical guidelines shortly.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kiesslich R et al. (2003) Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124: 880–888
Marion JF et al. (2008) Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 103: 2342–2349
Kiesslich R et al. (2007) Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132: 874–882
Rutter MD et al. (2004) Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 53: 256–260
Hurlstone DP et al. (2004) Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 126: 376–378
Dekker E et al. (2007) Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 39: 216–221
van den Broek FJ et al. (2008) Endoscopic tri-modal imaging for surveillance in ulcerative colitis: randomised comparison of high-resolution endoscopy and autofluorescence imaging for neoplasia detection; and evaluation of narrow-band imaging for classification of lesions. Gut 57: 1083–1089
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Table 1
Controlled studies on the use of chromoendoscopy in patients with ulcerative colitis (DOC 30 kb)
Rights and permissions
About this article
Cite this article
Neurath, M., Kiesslich, R. Is chromoendoscopy the new standard for cancer surveillance in patients with ulcerative colitis?. Nat Rev Gastroenterol Hepatol 6, 134–135 (2009). https://doi.org/10.1038/ncpgasthep1355
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1355
This article is cited by
-
Tumoren bei chronisch-entzündlichen Darmerkrankungen
Der Gastroenterologe (2015)
-
Von der Entzündung zum Karzinom
Der Gastroenterologe (2013)
-
Confocal laser endomicroscopy and narrow-band imaging-aided endoscopy for in vivo imaging of colitis and colon cancer in mice
Nature Protocols (2011)